Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
The book presents invaluable insights into the latest advancements, challenges, and research on vaccine adjuvants, which are key to developing more effective and safer vaccines essential for tackling pressing global health challenges.
Emerging Pathways of Vaccine Adjuvants: A Nonspecific Stimulant of the Immune System aims to drive progress in vaccine research, paving the way for the development of more potent and safer vaccines to address global health threats. This volume provides a comprehensive overview of the evolving landscape of vaccine adjuvants, encompassing a wide range of topics critical to their design, development, and application. Adjuvants play a crucial role in vaccine formulations by boosting the immunogenicity of antigens, thereby enhancing vaccine efficacy. While antigens can initiate immune responses independently, adjuvants amplify these responses. Extensive research efforts are focused on the formulation of adjuvants to establish accurate, efficient, and safe manufacturing techniques. This book provides a clear explanation of the strict regulatory issues, making it an essential resource for students, businesspeople, and academics across the globe.
Readers will find the book:
Audience
Researchers and pharmacy students in biomedical engineering and chemical engineering, biotechnology, as well as pharmaceutical and biopharmaceutical industry engineers working in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics.
Vivek P. Chavda is an assistant professor in the Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Gujarat, India with over eight years of teaching and biologics industry experience. He has more than 200 national and international publications, four edited books, an authored book, and 28 book chapters and is working on three patents. His research interests include the development of biologics processes and formulations, medical device development, nanodiagnostics and non-carrier formulations, long-acting parenteral formulations, and nanovaccines.
Vasso Apostolopoulos, PhD, is a Vice-Chancellor Distinguished Fellow and Director of the Immunology and Translational Research Group at Victoria University, Australia and the Immunology Program Director at the Australian Institute for Musculoskeletal Science, Australia. She is a world-renowned researcher with over 100 awards, 510 research publications, and 22 patents to her credit. Her interests include vaccine and drug development for cancer, chronic, infectious, and autoimmune diseases.
Preface xv
1 Adjuvants Boosting Vaccine Effectiveness 1Vasso Apostolopoulos
2 In Silico Adjuvant Design and Validation for Vaccines 15Vivek P. Chavda, Anjali P. Bedse, Pankti C. Balar, Bedanta Bhattacharjee, Shilpa S. Raut and Vasso Apostolopoulos
3 Adjuvant and Immunity 39Himel Mondal, Shaikat Mondal, Bairong Shen and Rajeev K. Singla
4 Antigen Selection and Design 73Pankti C. Balar, Anjali P. Bedse, Vivek P. Chavda, Chukwuebuka E. Umeyor, Prafull Kolekar, Brian O. Ogbonna, Ankita Anure, Daniel U. Eze, Payal Dodiya and Vandana B. Patravale
5 Adjuvants in Licensed Vaccines 107Kaushika Patel, Nandita Chawla, Yashvi Mehta and Sachin Patel
6 Nanomaterial-Based Vaccine Adjuvants 137Tanvi, Philips Kumar, Rajat Goyal, Kashish Wilson, Hitesh Chopra and Rajeev K. Singla
7 Adjuvants for Non-Invasive Routes of Vaccine Delivery 171Shruti U. Rawal, Tosha Pandya, Mangesh Kulkarni, Riya Patel and Anjali Menon
8 Regulatory Guidelines for Vaccine Adjuvants 211Suneetha Vuppu, Vivek P. Chavda, Toshika Mishra, Nikita Sharma and Sathvika Kamaraj
9 Adjuvant and Vaccine Safety 235Shalini Bhattacharya, Jyoti Singh, Rupesh K. Gautam, Nadeem Farooqui, Nimita Manocha and Hitesh Malhotra
10 Shortcomings of Current Adjuvants and Future Prospects 255Pankti C. Balar, Vasso Apostolopoulos and Vivek P. Chavda
References 260
Index 263
Dateiformat: PDFKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.
Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.